Aesyra reports significant reduction in sleep bruxism activity with AesyBite™ Active

Aesyra reports significant reduction in sleep bruxism activity with AesyBite™ Active

Aesyra announces the successful completion of a clinical investigation evaluating the efficacy and safety of AesyBite™ Active.

Read Now
Aesyra closes $3 Million financing round

Aesyra closes $3 Million financing round

Aesyra has raised $3 million in a financing round led by Supermoon Capital (USA), the world’s first fund focused on sleeptech, and deep tech investor Creadd Ventures (Switzerland) with participation from existing investor Zürcher Kantonalbank.

Read Now

Join our newsletter!

Please enter a valid email

We use cookies to make your browsing experience smoother.